Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Reply to Fabre et al.

McDonald LC, Johnson S, Bakken JS, Garey KW, Kelly C, Gerding DN.

Clin Infect Dis. 2018 Nov 28;67(12):1958-1959. doi: 10.1093/cid/ciy475. No abstract available.

PMID:
29860268
2.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.

Clin Infect Dis. 2018 Mar 19;66(7):987-994. doi: 10.1093/cid/ciy149.

PMID:
29562266
3.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH.

Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.

4.

The United Nations and the Urgent Need for Coordinated Global Action in the Fight Against Antimicrobial Resistance.

Boucher HW, Bakken JS, Murray BE.

Ann Intern Med. 2016 Dec 6;165(11):812-813. doi: 10.7326/M16-2079. Epub 2016 Sep 20. No abstract available.

PMID:
27653291
5.

R&D: Antibiotic partners promote discovery.

Bakken JS.

Nature. 2016 Sep 8;537(7619):167. doi: 10.1038/537167b. No abstract available.

PMID:
27604939
6.

Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations.

Bakken JS.

Microb Ecol Health Dis. 2015 May 29;26:27657. doi: 10.3402/mehd.v26.27657. eCollection 2015. No abstract available.

7.

Human granulocytic anaplasmosis.

Bakken JS, Dumler JS.

Infect Dis Clin North Am. 2015 Jun;29(2):341-55. doi: 10.1016/j.idc.2015.02.007. Review.

8.

Recovery of the gut microbiome following fecal microbiota transplantation.

Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, Young VB.

MBio. 2014 Jun 17;5(3):e00893-14. doi: 10.1128/mBio.00893-14.

9.

Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent Clostridium difficile infection.

Bakken JS.

Clin Infect Dis. 2014 Sep 15;59(6):858-61. doi: 10.1093/cid/ciu429. Epub 2014 Jun 9.

PMID:
24917658
10.

Reply to Solari et al.

Moore TA, Rodriguez A, Bakken JS.

Clin Infect Dis. 2014 Jul 15;59(2):319-20. doi: 10.1093/cid/ciu279. Epub 2014 Apr 23. No abstract available.

PMID:
24759828
11.

Fecal microbiota transplantation: a practical update for the infectious disease specialist.

Moore T, Rodriguez A, Bakken JS.

Clin Infect Dis. 2014 Feb;58(4):541-5. doi: 10.1093/cid/cit950. Epub 2013 Dec 23. Review.

PMID:
24368622
12.

Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.

Bakken JS, Polgreen PM, Beekmann SE, Riedo FX, Streit JA.

Anaerobe. 2013 Dec;24:20-4. doi: 10.1016/j.anaerobe.2013.08.007. Epub 2013 Sep 4.

PMID:
24012687
13.

Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.

Rubin TA, Gessert CE, Aas J, Bakken JS.

Anaerobe. 2013 Feb;19:22-6. doi: 10.1016/j.anaerobe.2012.11.004. Epub 2012 Nov 23.

PMID:
23182843
14.

Treating Clostridium difficile infection with fecal microbiota transplantation.

Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C; Fecal Microbiota Transplantation Workgroup.

Clin Gastroenterol Hepatol. 2011 Dec;9(12):1044-9. doi: 10.1016/j.cgh.2011.08.014. Epub 2011 Aug 24. Review.

15.

Antiscience and ethical concerns associated with advocacy of Lyme disease.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.

Lancet Infect Dis. 2011 Sep;11(9):713-9. doi: 10.1016/S1473-3099(11)70034-2.

16.

Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Sood SK, Weinstein A, Wormser GP.

J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21.

PMID:
21097940
17.

Fecal bacteriotherapy for recurrent Clostridium difficile infection.

Bakken JS.

Anaerobe. 2009 Dec;15(6):285-9. doi: 10.1016/j.anaerobe.2009.09.007. Epub 2009 Sep 22. Review.

PMID:
19778623
19.

Human granulocytic anaplasmosis.

Bakken JS, Dumler S.

Infect Dis Clin North Am. 2008 Sep;22(3):433-48, viii. doi: 10.1016/j.idc.2008.03.011. Review.

PMID:
18755383
20.

Dispelling the chronic Lyme disease myth.

Kemperman MM, Bakken JS, Kravitz GR.

Minn Med. 2008 Jul;91(7):37-41.

PMID:
18714930
21.

Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.

Wormser GP, Barthold SW, Shapiro ED, Dattwyler RJ, Bakken JS, Steere AC, Bockenstedt LK, Radolf JD.

J Infect Dis. 2007 Dec 15;196(12):1865-6; author reply 1866-7. doi: 10.1086/523826. No abstract available.

PMID:
18190269
22.

A critical appraisal of "chronic Lyme disease".

Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood S, Weinstein A, Wong SJ, Zemel L.

N Engl J Med. 2007 Oct 4;357(14):1422-30. Review. No abstract available. Erratum in: N Engl J Med. 2008 Mar 6;358(10):1084. Agger, WA [added]; Artsob, H [added]; Auwaerter, P [added]; Dumler, JS [added]; Bakken, JS [added]; Bockenstedt, LK [added]; Green, J [added]; Dattwyler, RJ [added]; Munoz, J [added]; Nadelman, RB [added]; Schwartz, I [added]; Draper, T [added]; McSweegan,.

PMID:
17914043
23.

Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment.

Dumler JS, Madigan JE, Pusterla N, Bakken JS.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51. Review.

PMID:
17582569
24.

Human granulocytic anaplasmosis and macrophage activation.

Dumler JS, Barat NC, Barat CE, Bakken JS.

Clin Infect Dis. 2007 Jul 15;45(2):199-204. Epub 2007 Jun 5.

PMID:
17578779
25.

Clinical diagnosis and treatment of human granulocytotropic anaplasmosis.

Bakken JS, Dumler JS.

Ann N Y Acad Sci. 2006 Oct;1078:236-47. Review.

PMID:
17114714
26.

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB.

Clin Infect Dis. 2006 Nov 1;43(9):1089-134. Epub 2006 Oct 2. Erratum in: Clin Infect Dis. 2007 Oct 1;45(7):941.

PMID:
17029130
27.

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.

Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Ohl CA; Tickborne Rickettsial Diseases Working Group; CDC.

MMWR Recomm Rep. 2006 Mar 31;55(RR-4):1-27.

28.

Human granulocytic anaplasmosis and Anaplasma phagocytophilum.

Dumler JS, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, Grab DJ, Bakken JS.

Emerg Infect Dis. 2005 Dec;11(12):1828-34. Review.

29.

A case of Sweet syndrome associated with human granulocytic anaplasmosis.

Halasz CL, Niedt GW, Kurtz CP, Scorpio DG, Bakken JS, Dumler JS.

Arch Dermatol. 2005 Jul;141(7):887-9.

PMID:
16027306
30.

The fluoroquinolones: how long will their utility last?

Bakken JS.

Scand J Infect Dis. 2004;36(2):85-92. Review.

PMID:
15061660
31.

Babesiosis and HIV.

Froberg MK, Dannen D, Bakken JS.

Lancet. 2004 Feb 28;363(9410):704. No abstract available.

PMID:
15001329
32.

Successful treatment of human granulocytic ehrlichiosis in children using rifampin.

Krause PJ, Corrow CL, Bakken JS.

Pediatrics. 2003 Sep;112(3 Pt 1):e252-3.

PMID:
12949322
33.
34.

The value of an infectious diseases specialist.

Petrak RM, Sexton DJ, Butera ML, Tenenbaum MJ, MacGregor MC, Schmidt ME, Joseph WP, Kemmerly SA, Dougherty MJ, Bakken JS, Curfman MF, Martinelli LP, Gainer RB.

Clin Infect Dis. 2003 Apr 15;36(8):1013-7. Epub 2003 Mar 28.

PMID:
12684914
35.

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Aas J, Gessert CE, Bakken JS.

Clin Infect Dis. 2003 Mar 1;36(5):580-5. Epub 2003 Feb 14.

PMID:
12594638
36.
37.

The serological response of patients infected with the agent of human granulocytic ehrlichiosis.

Bakken JS, Haller I, Riddell D, Walls JJ, Dumler JS.

Clin Infect Dis. 2002 Jan 1;34(1):22-7. Epub 2001 Nov 21.

PMID:
11731941
38.

Proper nomenclature for the human granulocytic ehrlichiosis agent.

Bakken JS, Dumler JS.

Emerg Infect Dis. 2001 May-Jun;7(3):486. No abstract available.

39.

Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.

Bakken JS, Aguero-Rosenfeld ME, Tilden RL, Wormser GP, Horowitz HW, Raffalli JT, Baluch M, Riddell D, Walls JJ, Dumler JS.

Clin Infect Dis. 2001 Mar 15;32(6):862-70. Epub 2001 Mar 7.

PMID:
11247709
40.

Human granulocytic ehrlichiosis.

Bakken JS, Dumler JS.

Clin Infect Dis. 2000 Aug;31(2):554-60. Epub 2000 Sep 14. Review.

PMID:
10987720
41.

ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats.

Caturegli P, Asanovich KM, Walls JJ, Bakken JS, Madigan JE, Popov VL, Dumler JS.

Infect Immun. 2000 Sep;68(9):5277-83.

42.

Serum cytokine responses during acute human granulocytic ehrlichiosis.

Dumler JS, Trigiani ER, Bakken JS, Aguero-Rosenfeld ME, Wormser GP.

Clin Diagn Lab Immunol. 2000 Jan;7(1):6-8.

43.
44.

Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test.

Walls JJ, Aguero-Rosenfeld M, Bakken JS, Goodman JL, Hossain D, Johnson RC, Dumler JS.

J Clin Microbiol. 1999 Sep;37(9):2968-73.

45.

Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin.

Bakken JS, Goellner P, Van Etten M, Boyle DZ, Swonger OL, Mattson S, Krueth J, Tilden RL, Asanovich K, Walls J, Dumler JS.

Clin Infect Dis. 1998 Dec;27(6):1491-6.

PMID:
9868666
46.

[A new tick-borne disease--human granulocytic ehrlichiosis].

Bakken JS, Dumler JS, Kristiansen BE.

Tidsskr Nor Laegeforen. 1998 Oct 30;118(26):4117-8. Norwegian. No abstract available.

PMID:
9844520
47.

Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis.

Bakken JS, Erlemeyer SA, Kanoff RJ, Silvestrini TC 2nd, Goodwin DD, Dumler JS.

Clin Infect Dis. 1998 Nov;27(5):1323-4. No abstract available.

PMID:
9827293
48.
49.

The discovery of human granulocytotropic ehrlichiosis.

Bakken JS.

J Lab Clin Med. 1998 Sep;132(3):175-80. Review.

PMID:
9735922
50.

Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family.

Murphy CI, Storey JR, Recchia J, Doros-Richert LA, Gingrich-Baker C, Munroe K, Bakken JS, Coughlin RT, Beltz GA.

Infect Immun. 1998 Aug;66(8):3711-8.

Supplemental Content

Loading ...
Support Center